Clinical Trial Update: Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels [NA]

View source ↗

Summary

Completed clinical trial evaluating rosiglitazone (Avandia) on vascular outcomes in individuals with HIV infection and atherosclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• HIV Infection

Drugs mentioned

• Avandia (rosiglitazone)

Snippet

Sponsor: University of British Columbia | Conditions: Atherosclerosis, HIV Infections | NA | Status: COMPLETED